Effects of peptides derived from terminal modifications of the AΒ central hydrophobic core on AΒ fibrillization

ACS Chemical Neuroscience

Volumn 1, Issue 10, 2010, Pages 661-678

  Bett, Cyrus K ^a   Serem, Wilson K ^a   Fontenot, Krystal R ^a   Hammer, Robert P ^b   Garno, Jayne C ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b New England Peptide   (United States)

Author keywords

Amyloid peptide (A ); assembly; disassembly; fibrils; mitigators; spherical structures

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; OLIGOMER;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; FIBER; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN METABOLISM; PROTEIN MODIFICATION;

AMYLOID PEPTIDE (AΒ); ASSEMBLY; DISASSEMBLY; FIBRILS; MITIGATORS; SPHERICAL STRUCTURES;

AMYLOID; AMYLOID BETA-PEPTIDES; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; DRUG DESIGN; FLUORESCENCE; FLUORESCENT DYES; HUMANS; INDICATORS AND REAGENTS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE; THIAZOLES;

EID: 77958487672     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn900019r     Document Type: Article

References (57)

1. Selkoe, D. J. (1991) The molecular pathology of Alzheimers-disease Neuron 6, 487-498
2. Selkoe, D. J. (2003) Folding proteins in fatal ways Nature 426, 900-904
3. Tycko, R. (2003) Insights into the amyloid folding problem from solid-state NMR Biochemistry 42, 3151-3159
4. Baglioni, S., Casamenti, F., Bucciantini, M., Luheshi, L. M., Taddei, N., Chiti, F., Dobson, C. M., and Stefani, M. (2006) Prefibrillar amyloid aggregates could be generic toxins in higher organisms J. Neurosci. 26, 8160-8167
5. Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Self-assembly of A beta(1-42) into globular neurotoxins Biochemistry 42, 12749-12760
6. Hardy, J. and Selkoe, D. J. (2002) Medicine-The amyloid hypothesis of Alzheimers disease: Progress and problems on the road to therapeutics Science 297, 353-356
7. Walsh, D. M. and Selkoe, D. J. (2004) Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration Protein Peptide Lett. 11, 213-228
8. Walsh, D. M. and Selkoe, D. J. (2007) A beta Oligomers-a decade of discovery J. Neurochem. 101, 1172-1184
9. Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D., and Nakagawa, M. (2010) High-molecular-weight {beta}-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients FASEB J. 24, 2716-2726
10. Kemsley, J. (2009) Analyzing protein Drugs Chem. Eng. News 20-23
11. Tjernberg, L. O., Lilliehook, C., Callaway, D. J. E., Naslund, J., Hahne, S., Thyberg, J., Terenius, L., and Nordstedt, C. (1997) Controlling amyloid beta-peptide fibril formation with protease-stable ligands J. Biol. Chem. 272, 12601-12605
12. Tjernberg, L. O., Naslund, J., Lindqvist, F., Johansson, J., Karlstrom, A. R., Thyberg, J., Terenius, L., and Nordstedt, C. (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand J. Biol. Chem. 271, 8545-8548
13. Ghanta, J., Shen, C.-L., Kiessling, L. L., and Murphy, R. M. (1996) A strategy for designing inhibitors of b-amyloid toxicity J. Biol. Chem. 271, 29525-29528
14. Etienne, M. A., Aucoin, J. P., Fu, Y., McCarley, R. L., and Hammer, R. P. (2006) Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha, alpha-disubstituted amino acids J. Am. Chem. Soc. 128, 3522-3523
15. Gordon, D. J., Sciarretta, K. L., and Meredith, S. C. (2001) Inhibition of Β-amyloid(40) fibrillogenesis and disassembly of Β-amyloid(40) fibrils by short Β-amyloid congeners containing N-methyl amino acids at alternate residues Biochemistry 40, 8237-8245
16. Sciarretta, K. L., Gordon, D. J., and Meredith, S. C. (2006) Peptide-based inhibitors of amyloid assembly Methods Enzymol. 413, 273-312
17. Pallitto, M. M., Ghanta, J., Heinzelman, P., Kiessling, L. L., and Murphy, R. M. (1999) Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity Biochemistry 38, 3570-3578
18. Gordon, D. J., Tappe, R., and Meredith, S. C. (2002) Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits AΒ1-40 fibrillogenesis J. Pept. Res. 60, 37-55
19. Gordon, D. J. and Meredith, S. C. (2003) Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions Biochemistry 42, 475-485
20. Fu, Y. W., Gao, J. M., Bieschke, J., Dendle, M. A., and Kelly, J. W. (2006) Amide-to-E-olefin versus amide-to-ester backbone H-bond perturbations: Evaluating the O-O repulsion for extracting H-bond energies J. Am. Chem. Soc. 128, 15948-15949
21. Bieschke, J., Siegel, S. J., Fu, Y. W., and Kelly, J. W. (2008) Alzheimers A beta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s) Biochemistry 47, 50-59
22. Soto, C., Sigurdsson, E. M., Morelli, L., Kumar, R. A., Castano, E. M., and Frangione, B. (1998) Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimers therapy Nat. Med. 4, 822-826
23. Tanaka, M. (2007) Design and synthesis of chiral α,α- disubstituted amino acids and conformational study of their oligopeptides Chem. Pharm. Bull. (Tokyo) 55, 349-358
24. Ghanta, J., Shen, C.-L., Kiessling, L. L., and Murphy, R. M. (1996) A strategy for designing inhibitors of Β-amyloid toxicity J. Biol. Chem. 271, 29525-29528
25. Etienne, M. A., Aucoin, J. P., Fu, Y. W., McCarley, R. L., and Hammer, R. P. (2006) Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids J. Am. Chem. Soc. 128, 3522-3523
26. Li, Q. Y., Gordon, M., Etienne, M. A., Hammer, R. P., and Morgan, D. (2008) Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition Cell Transplant 17, 397-408
27. Bett, C. K., Ngunjiri, J. N., Serem, W. K., Fontenot, K. R., Hammer, R. P., McCarley, R. L., and Garno, J. C. (2010) Structure-activity relationships in peptide modulators of Β-amyloid protein aggregation: Variation in alpha,alpha-disubstitution results in altered aggregate size and morphology, ACS Chem. Neurosci. [online early access], DOI: 10.1021/cn100045q.
28. Formaggio, F., Bettio, A., Moretto, V., Crisma, M., Toniolo, C., and Broxterman, Q. B. (2003) Disruption of the beta-sheet structure of a protected pentapeptide, related to the beta-amyloid sequence 17-21, induced by a single, helicogenic C-alpha-tetrasubstituted alpha-amino acid J. Pept. Sci. 9, 461-466
29. Gilead, S. and Gazit, E. (2004) Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid Angew. Chem., Int. Ed. 43, 4041-4044
30. Cairo, C. W., Strzelec, A., Murphy, R. M., and Kiessling, L. L. (2002) Affinity-Based Inhibition of beta-Amyloid Toxicity Biochemistry 41, 8620-8629
31. Austen, B. M., Paleologou, K. E., Ali, S. A. E., Qureshi, M. M., Allsop, D., and El-Agnaf, O. M. A. (2008) Designing peptide inhibitors for oligomerization and toxicity of Alzheimers beta-amyloid peptide Biochemistry 47, 1984-1992
32. Li, Q., Gordon, M., Etienne Marcus, A., Hammer Robert, P., and Morgan, D. (2008) Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition Cell Transplant 17, 397-408
33. Etienne, M. A., Aucoin, J. P., Fu, Y., McCarley, R. L., and Hammer, R. P. (2006) Stoichiometric inhibition of amyloid beta -protein aggregation with peptides containing alternating alpha, alpha-disubstituted amino acids J. Am. Chem. Soc. 128, 3522-3523
34. Krebs, M. R. H., Bromley, E. H. C., and Donald, A. M. (2005) The binding of thioflavin-T to amyloid fibrils: localisation and implications J. Struct. Biol. 149, 30-37
35. Levine, H. (1993) Thioflavine-T interaction with synthetic Alzheimers-disease beta-amyloid peptides: Detection of amyloid aggregation in solution Protein Sci. 2, 404-410
36. LeVine, H., III (1995) Thioflavine T interaction with amyloid beta-sheet structures Amyloid 2, 1-6
37. Nilsson, M. R. (2004) Techniques to study amyloid fibril formation in vitro Methods 34, 151-160
38. Lee, S., Fernandez, E. J., and Good, T. A. (2007) Role of aggregation conditions in structure, stability, and toxicity of intermediates in the A beta fibril formation pathway Protein Sci. 16, 723-732
39. Bieschke, J., Zhang, Q. H., Powers, E. T., Lerner, R. A., and Kelly, J. W. (2005) Oxidative metabolites accelerate Alzheimers amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation Biochemistry 44, 4977-4983
40. Laczko, I., Vass, E., Soos, K., Fulop, L., Zarandi, M., and Penke, B. (2008) Aggregation of A beta(1-42) in the presence of short peptides: conformational studies J. Pept. Sci. 14, 731-741
41. Gazit, E. (2005) Mechanisms of amyloid fibril self-assembly and inhibition FEBS J. 272, 5971-5978
42. Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., and Rydel, R. E. (2005) Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death J. Neurosci. 25, 1071-1080
43. Kad, N. M., Myers, S. L., Smith, D. P., Smith, D. A., Radford, S. E., and Thomson, N. H. (2003) Hierarchical assembly of beta(2)-microglobulin amyloid in vitro revealed by atomic force microscopy J. Mol. Biol. 330, 785-797
44. Paravastu, A. K., Petkova, A. T., and Tycko, R. (2006) Polymorphic fibril formation by residues 10-40 of the Alzheimers beta-amyloid peptide Biophys. J. 90, 4618-4629
45. Jarrett, J. T., Berger, E. P., and Lansbury, P. T. (1993) The carboxy terminus of the beta-amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimers-disease Biochemistry 32, 4693-4697
46. Soto, P., Griffin Mary, A., and Shea, J.-E. (2007) New insights into the mechanism of Alzheimer amyloid-beta fibrillogenesis inhibition by N-methylated peptides Biophys. J. 93, 3015-3025
47. Carulla, N., Caddy, G. L., Hall, D. R., Zurdo, J., Gairi, M., Feliz, M., Giralt, E., Robinson, C. V., and Dobson, C. M. (2005) Molecular recycling within amyloid fibrils Nature 436, 554-558
48. Fulop, L., Zarandi, M., Datki, Z., Soos, K., and Penke, B. (2004) beta-amyloid-derived pentapeptide RIIGL(a) inhibits A beta(1-42) aggregation and toxicity Biochem. Biophys. Res. Commun. 324, 64-69
49. El-Agnaf, O. M. A., Paleologou, K. E., Greer, B., Abogrein, A. M., King, J. E., Salem, S. A., Fullwood, N. J., Benson, F. E., Hewitt, R., Ford, K. J., Martin, F. L., Harriot, P., Cookson, M. R., and Allsop, D. (2004) A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinsons disease and related disorders FASEB J. 18, 1315-+
50. Schmechel, A., Zentgraf, H., Scheuermann, S., Fritz, G., Pipkorn, R. D., Reed, J., Beyreuther, K., Bayer, T. A., and Multhaup, G. (2003) Alzheimer beta-amyloid homodimers facilitate A beta fibrillization and the generation of conformational antibodies J. Biol. Chem. 278, 35317-35324
51. Morimoto, A., Irie, K., Murakami, K., Masuda, Y., Ohigashi, H., Nagao, M., Fukuda, H., Shimizu, T., and Shirasawa, T. (2004) Analysis of the secondary structure of beta-amyloid (A beta 42) fibrils by systematic proline replacement J. Biol. Chem. 279, 52781-52788
52. Sato, T., Kienlen-Campard, P., Ahmed, M., Liu, W., Li, H. L., Elliott, J. I., Aimoto, S., Constantinescu, S. N., Octave, J. N., and Smith, S. O. (2006) Inhibitors of amyloid toxicity based on beta-sheet packing of A beta 40 and A beta 42 Biochemistry 45, 5503-5516
53. ONuallain, B., Shivaprasad, S., Kheterpal, I., and Wetzel, R. (2005) Thermodynamics of abeta(1-40) amyloid fibril elongation Biochemistry 44, 12709-12718
54. Fu, Y. W. and Hammer, R. P. (2002) Efficient acylation of the N-terminus of highly hindered C-alpha,C-alpha-disubstituted amino acids via amino acid symmetrical anhydrides Org. Lett. 4, 237-240
55. Fu, Y. W., Hammarstrom, L. G. J., Miller, T. J., Fronczek, F. R., McLaughlin, M. L., and Hammer, R. P. (2001) Sterically hindered C-alpha,C-alpha-disubstituted alpha-amino acids: Synthesis from alpha-nitroacetate and incorporation into peptides J. Org. Chem. 66, 7118-7124
56. Fu, Y. W., Etienne, M. A., and Hammer, R. P. (2003) Facile synthesis of alpha,alpha-diisobutylglycine and anchoring its derivatives onto PAL-PEG-PS resin J. Org. Chem. 68, 9854-9857
57. Etienne, M. A., Edwin, N. J., Aucoin, J. P., Russo, P. S., McCarley, R. L., and Hammer, R. P. (2007) beta-Amyloid protein aggregation Methods Mol. Biol. 386, 203-225